Companies:
50,318
Total Market Cap:
143052092937805.07
Inhibrx Biosciences
NASDAQ: INBX
Healthcare
Biotechnology
Global Rank
#17715
Country Rank
#2814
Market Cap
310.8 M
Price
21.47
Change (%)
0.33%
Volume
1,800
Inhibrx Biosciences's latest marketcap:
310.8 M
As of 08/12/2025, Inhibrx Biosciences's market capitalization has reached $310.8 M. According to our data, Inhibrx Biosciences is the 17715th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 310.8 M |
| Revenue (ttm) | 200,000 |
| Net Income (ttm) | 1.72 B |
| Shares Out | 14.48 M |
| EPS (ttm) | 111.58 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/30/2024 |
| Earnings Date | 08/19/2025 |
Market Cap Chart
Data Updated: 08/12/2025
Inhibrx Biosciences's yearly market capitalization.
Inhibrx Biosciences has seen its market value grow from $222.93 M to $310.8 M since 2024, representing a total increase of 39.42% and an annual compound growth rate (CAGR) of 71.65%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 08/12/2025 | $310.8 M | 36.75% | 17715 |
| 12/31/2024 | $222.93 M | 18330 |
Company Profile
Inhibrx Biosciences was founded in 2010 in United States.
The company went public on 08/19/2020
on the Nasdaq Stock Market.
With 161 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Inhibrx Biosciences's (INBX) current market cap?As of 08/12/2025, Inhibrx Biosciences (including the parent company, if applicable) has an estimated market capitalization of $310.8 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Inhibrx Biosciences (INBX) rank globally by market cap?Inhibrx Biosciences global market capitalization ranking is approximately 17715 as of 08/12/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.